- Home
- Products
Truseltiq (Infigratinib)
Truseltiq (Infigratinib)
Medicine Name: Truseltiq
Generic Name: Infigratinib
Dosage Form & Strength: Capsules – 25 mg and 100 mg
Manufactured By: BridgeBio Pharma, Inc.
Truseltiq (Infigratinib) is a kinase inhibitor indicated for adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement.
Recommended Dosage:
- Standard Dose: 125 mg orally once daily (one 100 mg capsule + one 25 mg capsule) for 21 days, followed by 7 days off, in 28-day cycle
- Administration: Take on an empty stomach (at least 1 hour before or 2 hours after food), at the same time daily. Swallow whole with water.
- Missed Dose: If a dose is missed by ≥4 hours or vomiting occurs, skip the dose and resume the next day
Dosage Adjustments:
- Mild/Moderate Renal Impairment: 100 mg once daily (21 days on/7 days off)
- Mild Hepatic Impairment: 100 mg once daily
- Moderate Hepatic Impairment: 75 mg once daily
- Retinal Pigment Epithelial Detachment (RPED): May cause blurred vision. Perform OCT and eye exams at baseline, 1 month, 3 months, and every 3 months thereafter. Urgently refer if visual symptoms appear.
- Hyperphosphatemia: May lead to mineralization or calcification of tissues. Regular phosphate level monitoring required. Initiate phosphate-lowering therapy as needed.
- Pregnancy Risk: May cause fetal harm. Advise effective contraception during treatment and for 30 days after final dose (both males and females of reproductive potential).
Required Documents for Import:
- Valid prescription from a licensed doctor
- Patient’s diagnostic reports
- Government-issued ID proof
Order Confirmation:
- Confirmed upon receipt of required documentation and applicable import permit
Availability in India & Globally: Global Rare Meds facilitates legal access to Truseltiq across India (including Mumbai, Pune, Chennai, Hyderabad, Delhi, Bangalore, Ahmedabad, Kolkata, and more) and internationally.
For Inquiries:
- Phone/WhatsApp: +91-99675 15602
- Email:info@globalraremeds.com
Global Rare Meds sources Truseltiq from certified suppliers worldwide. Dispensing is supervised by registered pharmacists and shipped from our fulfillment facility in Ambernath, Thane District, with full compliance to regulatory norms.
We offer transparent pricing, secure packaging, and prompt delivery globally.
What is the generic name of Truseltiq®?
Infigratinib
Who manufactures Truseltiq®?
BridgeBio Pharma, Inc.
Is Truseltiq® FDA approved?
Yes. FDA approval granted on May 28, 2021.
What is the dosage form of Truseltiq®?
Capsules – 25 mg and 100 mg for oral use
What are the common side
effects of Truseltiq®?
Dry eye, nail toxicity, fatigue, stomatitis, dry mouth, hair loss, vision blurred, constipation, abdominal pain, diarrhea, dysgeusia, and skin dryness.
How should Truseltiq® be stored?
Store at 20°C to 25°C (68°F to 77°F); excursions allowed between 15°C and 30°C (59°F to 86°F).
Is it safe to buy Truseltiq® online in India?
Yes. Global Rare Meds provides legal, verifiable supply of Truseltiq through named patient programs.
How much does Truseltiq® cost in India?
Cost may vary. Contact us via WhatsApp at +91-99675 15602 or email info@globalraremeds.com for current pricing.
How to order Truseltiq®?
Submit a valid prescription and ID via email or WhatsApp. Orders are confirmed upon documentation review.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
